Stoke Therapeutics, Inc. ($STOK)
Filing Information
| Accession Number | 0001780088-26-000019 |
|---|---|
| Form Type | 4 |
| Filing Date | Aug 19, 2026 |
| Document | View SEC Filing |
Transactions
4
Total Shares
24,767
Total Value
$152,689.86
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CHIEF MEDICAL OFFICER | Common Stock | โ | Aug 14, 2026 | Exercise/Conversion | 10,000 | $0.00 | $0.00 | 30,422 | Direct | โ | View Details | |
CHIEF MEDICAL OFFICER | Common Stock | โ | Aug 18, 2026 | Sale | 4,525 | $32.01 | $144,832.58 | 25,897 | Direct | โ | View Details | |
CHIEF MEDICAL OFFICER | Common Stock | โ | Aug 18, 2026 | Sale | 242 | $32.47 | $7,857.28 | 25,655 | Direct | โ | View Details | |
CHIEF MEDICAL OFFICER | Performance Stock Units | Derivative | Aug 14, 2026 | Exercise/Conversion | 10,000 | $0.00 | $0.00 | 0 | Direct | โ | View Details |